Enright Patrick G's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Apr 5, 2022
- Accession no.
- 0000899243-22-013596
- Filed
- Apr 5, 2022
- Trade date
- Feb 10, 2022
- Filing delay
- 54 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $5.00M. It was filed 54 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Enright Patrick GCIK 0001253886 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Class A Common Stock | PPurchaseAcquired | +333,333 | $15.00 | +$4,999,995 | 3,429,927 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is being filed late due to an administrative error.